Seer, Inc. cotiza a 2.11 USD y tiene una capitalización bursátil de $117M. En los últimos 12 meses ha facturado $14M con un margen de flujo de caja libre del -278.9%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engine…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | — | $-0.30 | $-0.29 |
| Estimado | $-0.24 | $-0.27 | $-0.29 | $-0.32 |
| Sorpresa | — | — | -3.4% | +9.4% |
| Métrica | SEER | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 51.1% | 57.0% | -6.0% |
| Operating Margin | -470.4% | -38.6% | -431.8% |
| Net Margin | -444.0% | -33.6% | -410.4% |
| FCF Margin | -278.9% | -13.9% | -265.1% |
| ROE | -28.4% | -40.4% | +12.0% |
| ROA | -24.9% | -32.0% | +7.1% |
| Current Ratio | 12.84 | 2.84 | +10.00 |
| Debt / Equity | — | 0.28 | — |